Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2010 1
2011 1
2012 3
2013 6
2014 5
2015 2
2016 1
2017 9
2018 10
2019 5
2020 13
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Consensus guidelines for lumbar puncture in patients with neurological diseases.
Engelborghs S, Niemantsverdriet E, Struyfs H, Blennow K, Brouns R, Comabella M, Dujmovic I, van der Flier W, Frölich L, Galimberti D, Gnanapavan S, Hemmer B, Hoff E, Hort J, Iacobaeus E, Ingelsson M, Jan de Jong F, Jonsson M, Khalil M, Kuhle J, Lleó A, de Mendonça A, Molinuevo JL, Nagels G, Paquet C, Parnetti L, Roks G, Rosa-Neto P, Scheltens P, Skårsgard C, Stomrud E, Tumani H, Visser PJ, Wallin A, Winblad B, Zetterberg H, Duits F, Teunissen CE. Engelborghs S, et al. Among authors: gnanapavan s. Alzheimers Dement (Amst). 2017 May 18;8:111-126. doi: 10.1016/j.dadm.2017.04.007. eCollection 2017. Alzheimers Dement (Amst). 2017. PMID: 28603768 Free PMC article.
Protecting people with multiple sclerosis through vaccination.
Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J, Marta M, Turner B, Gnanapavan S, Dobson R, Schmierer K, Giovannoni G. Reyes S, et al. Among authors: gnanapavan s. Pract Neurol. 2020 Dec;20(6):435-445. doi: 10.1136/practneurol-2020-002527. Epub 2020 Jul 6. Pract Neurol. 2020. PMID: 32632038 Review.
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
Giovannoni G, Turner B, Gnanapavan S, Offiah C, Schmierer K, Marta M. Giovannoni G, et al. Among authors: gnanapavan s. Mult Scler Relat Disord. 2015 Jul;4(4):329-33. doi: 10.1016/j.msard.2015.04.006. Epub 2015 May 8. Mult Scler Relat Disord. 2015. PMID: 26195051 Free article. Review.
Science is 1% inspiration and 99% biomarkers.
Dubuisson N, Puentes F, Giovannoni G, Gnanapavan S. Dubuisson N, et al. Among authors: gnanapavan s. Mult Scler. 2017 Oct;23(11):1442-1452. doi: 10.1177/1352458517709362. Epub 2017 May 24. Mult Scler. 2017. PMID: 28537780 Review.
Developing Biomarkers for MS.
Gnanapavan S, Giovannoni G. Gnanapavan S, et al. Curr Top Behav Neurosci. 2015;26:179-94. doi: 10.1007/7854_2014_362. Curr Top Behav Neurosci. 2015. PMID: 25502545 Review.
Tuberculous tales: an East London experience.
Shah AM, Raciborska D, Stevens M, Gnanapavan S, White VLC, Turner B. Shah AM, et al. Among authors: gnanapavan s. Pract Neurol. 2017 Dec;17(6):429-438. doi: 10.1136/practneurol-2017-001653. Epub 2017 Aug 17. Pract Neurol. 2017. PMID: 28819046 Review.
Serum neurofilament-light concentration and real-world outcome in MS.
Anderson V, Bentley E, Loveless S, Bianchi L, Harding KE, Wynford-Thomas RA, Joseph F, Giovannoni G, Gnanapavan S, Robertson NP, Marta M, Tallantyre EC. Anderson V, et al. Among authors: gnanapavan s. J Neurol Sci. 2020 Oct 15;417:117079. doi: 10.1016/j.jns.2020.117079. Epub 2020 Aug 3. J Neurol Sci. 2020. PMID: 32781395
50 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page